Overview of Dr. Shah
Dr. Neil Shah is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Pramukhswami Medical College and has been in practice 7 years. He is one of 497 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 30 publications and over 500 citings.
Office
353 East 68th Street
New York, NY 10065
Education & Training
- MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 2016 - 2019
- Hackensack University Medical Center (Mountainside)Residency, Internal Medicine, 2012 - 2016
- Pramukhswami Medical CollegeClass of 2010
Certifications & Licensure
- FL State Medical License 2021 - Present
- NJ State Medical License 2014 - 2025
- NY State Medical License 2019 - 2024
- DC State Medical License 2016 - 2020
- VA State Medical License 2017 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsCabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial.Kelly N Fitzgerald, Chung-Han Lee, Martin H Voss, Maria I Carlo, Andrea Knezevic
European Urology. 2024-08-01 - A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer.Ritesh R Kotecha, Sahil D Doshi, Andrea Knezevic, Joshua Chaim, Yingbei Chen
European Urology Oncology. 2024-08-01 - Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma.Neil J Shah, Reshma Shinde, Kristin J Moore, Amy Sainski-Nguyen, Lisa B Le
JAMA Network Open. 2024-07-01
Press Mentions
- New Combo Immunotherapy Prolongs Survival in Patients with Advanced Kidney CancerApril 22nd, 2022
- Patient Groups Untested in Cancer Immunotherapy Trials Found to Also BenefitMay 30th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: